Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
about
Immunohistochemical Markers as Predictors of Histopathologic Response and Prognosis in Rectal Cancer Treated with Preoperative Adjuvant Therapy: State of the Art.Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour
P2860
Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@ast
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@en
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@nl
type
label
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@ast
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@en
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@nl
prefLabel
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@ast
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@en
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@nl
P2093
P2860
P50
P356
P1433
P1476
Dihydropyrimidine Dehydrogenas ...... reatment of Recurrent Gliomas.
@en
P2093
Da-Young Chang
Dong Soo Lee
Ho Eun Moon
Hyeonjin Kim
June-Key Chung
Sun Ha Paek
Sung-Soo Kim
Taemoon Chung
Young Il Kim
P2860
P304
P356
10.7150/THNO.14158
P577
2016-06-17T00:00:00Z